Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eric Davis

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Discover Oncology|June 17, 2024
Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastasesEswaran Devarajan, R Eric Davis, Hannah C Beird, et al.
Blood|April 9, 2013
Prognostic impact and targeting of CRM1 in acute myeloid leukemiaKensuke Kojima, Steven M Kornblau, Vivian Ruvolo, et al.
Cancer Research|March 2, 2018
Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 InhibitionJo Ishizawa, Kenji Nakamaru, Takahiko Seki, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AMLShelley Herbrich, Natalia Baran, Tianyu Cai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013
Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironmentSeema Rawal, Fuliang Chu, Min Zhang, et al.
The Journal of Clinical Investigation|March 5, 2019
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironmentSujan Piya, Hong Mu, Seemana Bhattacharya, et al.
Journal of the National Cancer Institute|June 28, 2018
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in GliomaKhatri Latha, Jun Yan, Yuhui Yang, et al.
International Journal of Cancer|April 29, 2014
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphomaKui Shin Voo, Myriam Foglietta, Elena Percivalle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2018
Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Discover Oncology|June 17, 2024
Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastasesEswaran Devarajan, R Eric Davis, Hannah C Beird, et al.
Blood|April 9, 2013
Prognostic impact and targeting of CRM1 in acute myeloid leukemiaKensuke Kojima, Steven M Kornblau, Vivian Ruvolo, et al.
Cancer Research|March 2, 2018
Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 InhibitionJo Ishizawa, Kenji Nakamaru, Takahiko Seki, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AMLShelley Herbrich, Natalia Baran, Tianyu Cai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013
Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironmentSeema Rawal, Fuliang Chu, Min Zhang, et al.
The Journal of Clinical Investigation|March 5, 2019
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironmentSujan Piya, Hong Mu, Seemana Bhattacharya, et al.
Journal of the National Cancer Institute|June 28, 2018
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in GliomaKhatri Latha, Jun Yan, Yuhui Yang, et al.
International Journal of Cancer|April 29, 2014
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphomaKui Shin Voo, Myriam Foglietta, Elena Percivalle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2018
Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, et al.
Pageof 9